1. Home
  2. GPCR
  3. GPCR News

Latest Structure Therapeutics Inc. (GPCR) News on April 24, 2025

Eli Lilly jumps as results from weight-loss pill study rival competitor’s
GPCR

TipRanks

6 days ago

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
GPCR

TipRanks

6 days ago

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
GPCR

TipRanks

9 days ago

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
GPCR

Zacks

9 days ago

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
GPCR

Investor's Business Daily

2 months ago

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

GPCR

MT Newswires

2 months ago

William Blair Initiates Structure Therapeutics at Outperform

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
GPCR

GlobeNewswire

2 months ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights

Why Structure Therapeutics Stock Was Stumbling This Week
GPCR

Motley Fool

2 months ago

Why Structure Therapeutics Stock Was Stumbling This Week

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GPCR

GlobeNewswire

3 months ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate
GPCR

Simply Wall St.

3 months ago

We're Not Very Worried About Structure Therapeutics' (NASDAQ:GPCR) Cash Burn Rate

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.
GPCR

Barrons.com

4 months ago

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
GPCR

GlobeNewswire

4 months ago

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
GPCR

Insider Monkey

4 months ago

Is Structure Therapeutics Inc. (GPCR) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
GPCR

TipRanks

5 months ago

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

GPCR

MT Newswires

5 months ago

HC Wainwright Initiates Structure Therapeutics at Buy

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?
GPCR

Insider Monkey

5 months ago

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
GPCR

Insider Monkey

5 months ago

Structure Therapeutics Inc. (GPCR): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
GPCR

GlobeNewswire

5 months ago

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
GPCR

GlobeNewswire

5 months ago

Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity
GPCR

GlobeNewswire

5 months ago

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024
GPCR

GlobeNewswire

6 months ago

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2024

GPCR drugmaker Septerna amasses $288M in IPO
GPCR

BioPharma Dive

6 months ago

GPCR drugmaker Septerna amasses $288M in IPO

Structure Therapeutics (GPCR): Innovating Oral Therapies for Obesity and Diabetes
GPCR

Insider Monkey

6 months ago

Structure Therapeutics (GPCR): Innovating Oral Therapies for Obesity and Diabetes

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?
GPCR

Zacks

7 months ago

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
GPCR

Investor's Business Daily

7 months ago

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?
GPCR

Insider Monkey

7 months ago

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?

GPCR

MT Newswires

7 months ago

Structure Therapeutics Shares Rise After Morgan Stanley Begins Coverage at Overweight

GPCR

MT Newswires

7 months ago

Morgan Stanley Initiates Structure Therapeutics at Overweight

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill
GPCR

The Wall Street Journal

7 months ago

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill

GPCR

MT Newswires

7 months ago

Structure Therapeutics Names Chief Medical Officer, Chief Development Officer

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
GPCR

GlobeNewswire

7 months ago

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
GPCR

Zacks

7 months ago

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise

Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now
GPCR

Insider Monkey

8 months ago

Structure Therapeutics Inc. (GPCR): Among the Best Mid-Cap Healthcare Stocks To Buy Now

Structure Therapeutics Appoints Angus C. Russell to Board of Directors
GPCR

GlobeNewswire

8 months ago

Structure Therapeutics Appoints Angus C. Russell to Board of Directors

Structure Therapeutics Announces Participation in Upcoming Investor Conferences
GPCR

GlobeNewswire

8 months ago

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth
GPCR

Simply Wall St.

8 months ago

Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth

Don’t Forget This Startup’s Weight-Loss Pill, Analyst Says
GPCR

Barrons.com

8 months ago

Don’t Forget This Startup’s Weight-Loss Pill, Analyst Says

Don’t Forget This Start-Up’s Weight-Loss Pill, Analyst Says
GPCR

Barrons.com

8 months ago

Don’t Forget This Start-Up’s Weight-Loss Pill, Analyst Says

Why Are Hedge Funds Bullish on Structure Therapeutics Inc. (GPCR) Now?
GPCR

Insider Monkey

9 months ago

Why Are Hedge Funds Bullish on Structure Therapeutics Inc. (GPCR) Now?

Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
GPCR

GlobeNewswire

9 months ago

Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?
GPCR

Zacks

9 months ago

What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
GPCR

Benzinga

9 months ago

Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

Could Structure Therapeutics Become the Next Novo Nordisk?
GPCR

Motley Fool

10 months ago

Could Structure Therapeutics Become the Next Novo Nordisk?

Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
GPCR

Zacks

10 months ago

Structure Therapeutics (GPCR) Rallying on Obesity Drug Data

Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
GPCR

Motley Fool

10 months ago

Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?

Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
GPCR

Motley Fool

10 months ago

Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?

GPCR

MT Newswires

a year ago

Structure Therapeutics Closes $547.4 Million Offering

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares

GPCR

MT Newswires

a year ago

BMO Capital Adjusts Price Target on Structure Therapeutics to $100 From $83, Maintains Outperform Rating

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
GPCR

GlobeNewswire

a year ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
GPCR

PR Newswire

a year ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
GPCR

GlobeNewswire

a year ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
GPCR

GlobeNewswire

a year ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
GPCR

Insider Monkey

a year ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
GPCR

GlobeNewswire

a year ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages
GPCR

PR Newswire

a year ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032
GPCR

GlobeNewswire

a year ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

GPCR

MT Newswires

a year ago

Structure Therapeutics Prices Upsized $476 Million Stock Offering

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

Heard on the Street Monday Recap: Catnip
GPCR

The Wall Street Journal

a year ago

Heard on the Street Monday Recap: Catnip

GPCR

MT Newswires

a year ago

Structure Therapeutics Plans Offering of American Depositary Shares

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants

GPCR

MT Newswires

a year ago

Top Midday Gainers

Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
GPCR

Investor's Business Daily

a year ago

Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results

GPCR

MT Newswires

a year ago

Structure Therapeutics Reports Positive Topline Data From Obesity Trial; Shares Jump

Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.
GPCR

The Wall Street Journal

a year ago

Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.

Structure Therapeutics Stock Soars on Obesity Pill Data
GPCR

The Wall Street Journal

a year ago

Structure Therapeutics Stock Soars on Obesity Pill Data

Structure pill leads to competitive weight loss in obesity study
GPCR

BioPharma Dive

a year ago

Structure pill leads to competitive weight loss in obesity study

Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290

J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
GPCR

TipRanks

a year ago

J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks

GPCR

MT Newswires

a year ago

JPMorgan Starts Structure Therapeutics With Overweight Rating

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth
GPCR

Simply Wall St.

a year ago

We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
GPCR

GlobeNewswire

a year ago

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
GPCR

GlobeNewswire

a year ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

3 Stocks to Buy for Consistent Sales Growth
GPCR

Zacks

a year ago

3 Stocks to Buy for Consistent Sales Growth

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
GPCR

CNW Group

a year ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

GPCR

Business Wire

a year ago

Form 8.3 - DX (Group) plc

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030
GPCR

GlobeNewswire

a year ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

Copa Holdings (CPA) Stock Moves -0.07%: What You Should Know
GPCR

Zacks

a year ago

Copa Holdings (CPA) Stock Moves -0.07%: What You Should Know

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations
GPCR

Simply Wall St.

a year ago

Valley National Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Capital One (COF) Reports Q4 Earnings: What Key Metrics Have to Say
GPCR

Zacks

a year ago

Capital One (COF) Reports Q4 Earnings: What Key Metrics Have to Say

Booz Allen (BAH) Invests in Albedo For VLEO Satellite Imaging
GPCR

Zacks

a year ago

Booz Allen (BAH) Invests in Albedo For VLEO Satellite Imaging

AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow
GPCR

Investor's Business Daily

a year ago

AbbVie Stock Moves With Rising Relative Strength, Still Room To Grow

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
GPCR

Zacks

a year ago

Here's Why You Should Add Xenon (XENE) to Your Portfolio Now

Here’s Why Structure Therapeutics (GPCR) Fell in Q4
GPCR

Insider Monkey

a year ago

Here’s Why Structure Therapeutics (GPCR) Fell in Q4

SITE Centers Announces Tax Allocations of 2023 Dividend Distributions
GPCR

Business Wire

a year ago

SITE Centers Announces Tax Allocations of 2023 Dividend Distributions

GOGL – Changes to the Board composition
GPCR

GlobeNewswire

a year ago

GOGL – Changes to the Board composition

Where Will Marathon Digital Stock Be in 10 Years?
GPCR

Motley Fool

a year ago

Where Will Marathon Digital Stock Be in 10 Years?

Here is Why Growth Investors Should Buy Silicon Motion (SIMO) Now
GPCR

Zacks

a year ago

Here is Why Growth Investors Should Buy Silicon Motion (SIMO) Now

With EPS Growth And More, RBC Bearings (NYSE:RBC) Makes An Interesting Case
GPCR

Simply Wall St.

a year ago

With EPS Growth And More, RBC Bearings (NYSE:RBC) Makes An Interesting Case

HashiCorp Inc CMO Marc Holmes Sells 13,916 Shares
GPCR

GuruFocus.com

a year ago

HashiCorp Inc CMO Marc Holmes Sells 13,916 Shares

Polestar announces Board and Management appointments
GPCR

Business Wire

a year ago

Polestar announces Board and Management appointments

Freshworks to Participate in 26th Annual Needham Growth Conference
GPCR

GlobeNewswire

a year ago

Freshworks to Participate in 26th Annual Needham Growth Conference

ADP appoints Thomas J. Lynch as the new Independent Board Chair
GPCR

PR Newswire

a year ago

ADP appoints Thomas J. Lynch as the new Independent Board Chair

AWR vs. SJW: Which Dividend King is the Better Buy?
GPCR

TipRanks

a year ago

AWR vs. SJW: Which Dividend King is the Better Buy?

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
GPCR

InvestorPlace

a year ago

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
GPCR

Zacks

a year ago

3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024

Pilgrim's Pride Stock Shows Market Leadership With Jump To 83 RS Rating
GPCR

Investor's Business Daily

a year ago

Pilgrim's Pride Stock Shows Market Leadership With Jump To 83 RS Rating

Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
GPCR

Motley Fool

a year ago

Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now

Share on Social Networks: